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Purpose: This study analyses seminal vesicle displacement relative to the prostate and in relation to treatment
time.
Method: A group of eleven patients undergoing prostate cancer radiotherapy were imaged with a continuous 3 T
cine-MRI in the standard treatment setup position. Four images were recorded every 4 seconds for 15 minutes in
the sagittal plane and every 6.5 seconds for 12 minutes in the coronal plane. The prostate gland and seminal
vesicles were contoured on each MRI image. The coordinates of the centroid of the prostate and seminal vesicles
on each image was analysed for displacement against time. Displacements between the 2.5 percentile and 97.5
percentile (i.e. the 2.5% trimmed range) for prostate and seminal vesicle centroid displacements were measured for
3, 5, 10 and 15 minutes time intervals in the anterior-posterior (AP), left-right (LR) and superior-inferior (SI) directions.
Real time prostate and seminal vesicle displacement was compared for individual patients.
Results: The 2.5% trimmed range for 3, 5, 10 and 15 minutes for the seminal vesicle centroids in the SI direction
measured 4.7 mm; 5.8 mm; 6.5 mm and 7.2 mm respectively. In the AP direction, it was 4.0 mm, 4.5 mm, 6.5 mm,
and 7.0 mm. In the LR direction for 3, 5 and 10 minutes; for the left seminal vesicle, it was 2.7 mm, 2.8 mm, 3.4 mm
and for the right seminal vesicle, it was 3.4 mm, 3.3 mm, and 3.4 mm. The correlation between the real-time
prostate and seminal vesicle displacement varied substantially between patients indicating that the relationship
between prostate displacement and seminal vesicles displacement is patient specific with the majority of the
patients not having a strong relationship.
Conclusion: Our study shows that seminal vesicle motion increases with treatment time, and that the prostate and
seminal vesicle centroids do not move in unison in real time, and that an additional margin is required for
independent seminal vesicle motion if treatment localisation is to the prostate.Introduction
The seminal vesicles are included in the clinical target
volume (CTV) for prostate cancer radiotherapy usually
in patients deemed to have a risk of invasion above 15%
according to Partin tables or the Roach equation [1,2].
Although including the seminal vesicles in the CTV
leads to a larger planning target volume (PTV) and irradi-
ation of a larger volume of adjacent rectum and bladder,
with modern techniques such as intensity-modulated
radiotherapy (IMRT), including the seminal vesicles has* Correspondence: suki.gill@petermac.org
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unless otherwise stated.been shown to be achievable with only a small increase
in normal tissue complication probability [3]. However,
IMRT, volumetric modulated arc therapy and stereotac-
tic body radiotherapy have sharp dose gradients outside
the intended target, and an accurate assessment of
radiotherapy margins is necessary.
Image-guided radiotherapy (IGRT) in prostate cancer
improves the accuracy of treatment delivery and has
been shown to reduce toxicity [4,5]. IGRT for prostate
cancer can be conducted with pretreatment imaging and
registration to fiducial markers implanted in the prostate
which corrects for interfraction displacement [4,6]. Inter-
fraction motion of the seminal vesicles has been reported
previously by assessing serial pretreatment images taken
during prostate cancer radiotherapy [7-9]. However with. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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same localization applies to the seminal vesicles and there-
fore the same CTV to PTV margins can be used for intra-
fraction motion of the seminal vesicles.
Cine MRI is a useful modality which can continually
monitor motion of internal organs without exposing the
patient to ionizing radiation. It has been used previously
to study the intrafraction motion of the prostate [10-15].
We conducted the present study to analyse if the magni-
tude of displacement of the seminal vesicles was similar
to that of the prostate, to see if the same margins could
be applied in the setting of IGRT.
Method
This study was approved by the local institutional ethics
board Peter MacCallum Cancer Centre Ethics Committee
prior to commencement. Prior to starting radiotherapy for
prostate cancer, eleven patients underwent a cine-MRI in
a time frame compatible with a standard IGRT fraction
delivery time. Disease stage for each patient are shown in
Table 1. All patients were instructed to empty their blad-
der and bowel one hour before the scan and then to drink
750 mls of water to follow the same department prepar-
ation protocol as prior to a standard prostate radiotherapy
fraction. Patients were positioned as for radiotherapy de-
livery, supine on the MRI couch (flat table) and stabilized
with a knee rest and foot stocks.
All patients underwent a True-FISP (Fast Imaging in
Steady-state Precession) T2 weighted cine-MRI scans on
a Siemens 3-tesla Tim Trio MRI system (Siemens Med-
ical Solutions, Malvern, PA). The MRI scanning protocol
consisted of an alternation of three 3D volume and two
cine-MRI acquisitions (Sagittal; TR-5.11 ms, TE-2.56 ms,
Thick-5 mm, Space-10 mm, Slices-4, FOV-360 mm,
Matrix-512×333, Voxel size-0.9×0.7×5.0 mm, Phase encod-
ing direction-A > P, Bandwidth-543 Hz/Px and Coronal;
TR-5.01 ms, TE-2.51 ms, Thick-5 mm, Space-10 mm,
Slices-4, FOV-380 mm, Matrix-512×410 mm, VoxelTable 1 Disease stage for each patient
Patient number T stage Gleason score Pre-RT PSA
1 T3b 3 + 4 12.2
2 T2c 3 + 4 19.1
3 T2c 3 + 4 20.6
4 T2b 4 + 4 15.9
5 T1c 3 + 4 12.4
6 T1c 3 + 3 12.5
7 T2b 4 + 3 18.3
8 T3b 4 + 3 9.3
9 T1c 3 + 3 7.6
10 T2a 3 + 3 7.5
11 T2b 3 + 4 7.8size-0.9×0.7×5.0 mm, Phase encoding direction-R > L,
Bandwidth-543 Hz/Px). With these parameters, the chem-
ical shift is 440/543 pixels, or about 0.6 mm in the fre-
quency encoding direction. We have previously published
on our treatment times for prostate cancer IGRT [16].
The median time for IGRT treatment was 6 minutes for
kilovoltage orthogonal imaging with automated couch
shift versus 10 minutes for megavoltage orthogonal im-
aging and manual couch shift. Setup time ranged from 3.0
to 6.2 mins (mean 4.8 mins). Therefore prostate IGRT
treatment time can vary from 9–16 minutes depending on
equipment. Total MRI scan time was 30 minutes, of which
15 minutes were in the sagittal plane, and 12 minutes in
the coronal plane. Four images were recorded every
4 seconds for 15 minutes in the sagittal plane followed
by four images every 6.5 seconds for 12 minutes in the
coronal plane. All coronal datasets represented a time
frame of 12 minutes, because we were limited to a
30 minute appointment slot for each patient.
Prostate and seminal vesicles were manually contoured
in the sagittal and coronal planes on every frame using
customised software written in VB.NET. The contouring
was conducted by one investigator (KD) and checked by a
second investigator (SG). This software catalogued the
large number of images (up to 1000 per patient) and orga-
nised them according to the reconstructed plane. Tools
were provided to draw and manipulate organ contours on
these images and to save the contours to a text file. A sec-
ond program analysed the contour information for each
image from the text files to find either the centroid of a
contour, the position of a point, or the distance across a
contour along a specified axis (see Figure 1). TheFigure 1 Toccata; in house software on which the prostate and
seminal vesicles were contoured, this example showing a sagittal
image contour.
Figure 2 Prostate AP displacement in millimeters (solid line) and sem
of origin over time in minutes. Each graph represents one patient.
Table 2 Comparison of prostate and seminal vesicles






(SD)Mean SD Mean SD
Saggital AP 3 min 3.6 1 4 1.4 0.413 0.221
AP 5 min 4.2 1.3 4.5 1.7 0.831 0.326
AP 10 min 5.3 2.1 6.5 4.1 0.831 0.049
AP 15 min 5.3 1.9 7 3.6 0.054 0.06
SI 3 min 3.3 0.7 4.7 2.8 0.01 <0.001
SI 5 min 4.4 1.8 5.8 3.4 0.042 0.083
SI 10 min 5.1 1.5 6.5 3.9 0.067 0.009
SI 15 min 5.3 1.6 7.2 4 0.019 0.009
Coronal Lt SV LR 3 min 3 1.7 2.7 1.3 0.625 0.469
Lt SV LR 5 min 3 1.4 2.8 1.4 0.695 0.92
Lt SV LR 10 min 3.1 1.7 3.4 1.6 0.322 0.846
Rt SV LR 3 min 3 1.7 3.4 1.9 0.557 0.694
Rt SV LR 5 min 3 1.4 3.3 1.7 0.322 0.645
Rt SV LR 10 min 3.1 1.7 3.4 1.8 0.322 0.864
The Wilcoxon test compares prostate and seminal vesicle displacement for
each of the four treatment durations. The F-test was used to compare the
variances of seminal vesicles and prostate displacement for each of the four
treatment durations.
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vesicle was analysed for each frame relative to the first
frame. Anterior-posterior (AP) and superior-inferior (SI)
displacement in time intervals (T) 3, 5, 10 and 15 minutes
from the start were analysed on sagittal images. Left-right
(LR) displacement in time intervals (T) 3, 5 and 10 minutes
from the start were analysed on coronal images.
To study the effect of treatment time on prostate and
seminal vesicle displacement, for each patient, the range
from the 2.5 percentile to the 97.5 percentile (2.5%
trimmed range) was calculated for the first 0 to 3 minutes,
0 to 5 minutes, 0 to 10 minutes and 0 to 15 minutes. The
reason we used the 2.5% trimmed range instead of pre-
senting the 95% confidence interval is because the confi-
dence interval assumes an underlying probability density
function (e.g. normal distribution) while our interest was
to provide a summary measure to describe the magnitude
of motion after removing the 5% most extreme values
(2.5% of each side). We chose to use the 2.5% trimmed
range instead of other popular trimmed ranges like
the interquartile range (25% trimmed range) and the
interdecile range (10% trimmed range) to exclude
only the most extreme observation but still captureinal vesicle AP displacement (dotted line) in relation to its point
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range have better clinical interpretation (as it corre-
sponds to the range for 95% of the displacement)
than the interquartile range (range for 50% of the
displacement).
The 2.5% trimmed ranges were compared between the
four observation durations using Friedman’s test. The
Wilcoxon test was used to compare the prostate and
seminal vesicle range of displacement for each of the
four treatment durations. The F-test was used to com-
pare the variances of seminal vesicles and prostate range
of displacement for each of the 4 treatment durations.
Spearman’s rank correlation was used to evaluate the re-
lationship between prostate and seminal vesicles range of
displacement. The Pearson product–moment correlation
coefficient was used to evaluate the relationship between
the movements of the prostate and seminal vesicles within
patient, for each individual patient.Results
A total of 11 sagittal datasets and 10 coronal datasets were
obtained, as one cine- MRI was terminated early by oneFigure 3 Prostate SI displacement in millimeters (solid line) and semi
origin over time in minutes. Each graph represents one patient.patient. 10 out of 11 sagittal dataset were taken for a time
length of 15 minutes and 1 dataset taken in 12 minutes.
The effect of treatment duration on seminal vesicle
displacement
On sagittal images, the average 2.5% trimmed range of
displacements for 3, 5, 10 and 15 minutes for seminal
vesicle centroids in the SI direction were 4.7, 5.8, 6.5,
7.2 mm respectively. In the AP direction, seminal vesicle
the average 2.5% trimmed range of displacements was 4.0,
4.5, 6.5 and 7.0 mm respectively for 3, 5, 10 and 15 minutes.
On coronal images, in the LR direction the average 2.5%
trimmed range of displacements for the left seminal vesicle
for the first 3, 5 and 10 minutes were 2.7, 2.8 and 3.4 mm
and for the right seminal vesicle, it was 3.4, 3.3 and 3.4 mm
respectively. The Friedman’s test showed that there was a
difference in the 2.5% trimmed range of displacements for
the seminal vesicles between the treatment’s durations for
the sagittal plane (p = 0.001 for AP direction and P < 0.001
in SI direction). The average 2.5% trimmed range of dis-
placements for the seminal vesicles significantly increases
as the duration of the treatment increases for the SI direc-
tion using sagittal image for all treatment durations.nal vesicle SI displacement (dotted line) in relation to its point of
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displacement for the group
The means and standard deviations and results of the
Wilcoxon test and F test comparing prostate and seminal
vesicle 2.5% trimmed range of displacements are given in
Table 2. The average range of prostate displacements and
seminal vesicle displacements increases with treatment
time, but this is more so for the seminal vesicles than
the prostates. The seminal vesicles move, on average,
more than the prostate in the sagittal plane for the SI
direction but not for the AP direction and p values are
as highlighted in Table 2. There was no difference in
displacement between prostate, right seminal vesicle
and left seminal vesicle for the LR direction.
The relationship between prostate and seminal vesicle
motion for each patient
Figures 2 and 3 show the prostate and seminal vesicle
displacement over time in the AP and SI directions for
each patient. While some patients had a strong relation-
ship between prostate and seminal vesicle displacement,Figure 4 The simultaneous displacement of the prostate and seminal
AP direction. Each graph represents one patient.others showed no relationship, indicating that the relation-
ship was patient specific. Some patients had a displace-
ment greater than 3 mm during a significant part of the
treatment. Except for one patient (patient 4), displacement
was hardly ever larger than 5 mm for the prostate in all
directions (sagittal and coronal planes). Figures 4 and 5
show the displacement of the prostate and seminal vesicle
at the same time-points compared to its point of origin in
the AP and SI directions. The prostate and seminal vesicle
displacement showed a linear trend for some patients, but
for the majority there is a random spread, indicating that
the displacement of the prostate was not related with
the displacement of the seminal vesicles. Table 3 shows
the Pearson product–moment correlation coefficient
for real-time prostate and seminal vesicle displacement
for each patient in the sagittal and coronal planes. The
Pearson product–moment correlation coefficient varied
substantially between patients indicating that the rela-
tionship between prostate displacement and seminal
vesicles displacement is patient specific with the ma-
jority not having a strong relationship.vesicles at each timepoint compared to its point of origin in the
Figure 5 The simultaneous displacement of the prostate and seminal vesicles at each timepoint compared to its point of origin in the
SI direction. Each graph represents one patient.
Table 3 Pearson product–moment correlation coefficient
between prostate and seminal vesicles displacement
(within patients)
Sagittal Coronal
Prostate vs. SV Prostate vs. right SV Prostate vs. left SV
Patient AP SI LR SI LR SI
1 0.19 0.00 - - - -
2 0.29 0.13 −0.28 0.28 −0.10 0.56
3 0.22 0.16 0.03 0.88 0.19 0.51
4 0.60 0.75 0.07 0.87 0.19 0.86
5 0.54 0.40 0.24 0.04 0.48 0.35
6 0.05 0.42 0.16 0.25 −0.23 0.07
7 0.82 0.23 0.09 0.35 0.13 0.35
8 0.72 0.57 0.11 0.72 0.23 0.22
9 0.61 0.29 0.29 0.28 0.15 0.29
10 0.17 0.12 0.04 0.01 −0.06 0.10
11 0.75 0.30 0.27 0.26 0.25 0.40
Note: The confidence interval varies depending on the correlation. The confidence
interval for 0 correlation is [−0.13; 0.13], for 0.5 correlation is [0.40; 0.60] and for
0.8 is [0.75; 0.85].
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Our analysis shows that the displacements in the SI
direction was significantly more for seminal vesicles
than for the prostate. Both the prostate and the sem-
inal vesicle displacements increase with treatment time
up to 10 minutes, but then appeared to plateau between
ten and fifteen minutes. The observation that displace-
ments plateaued after 10 minutes indicates that maximal
displacements for these organs (i.e. the prostate and sem-
inal vesicles) were reached, and that further displacements
beyond the maximum displacement is less likely to be
seen after ten minutes. This has implications for radiother-
apy margins; if treatment were given over time periods
shorter than 10 minutes, for example with VMAT, then
gains in terms of reduced margins are likely to be had.
However close monitoring of prostate motion is more ap-
propriate for longer treatment times, rather than larger
margins. Motion in the LR direction was seen to be min-
imal, with average displacement around 3 mm. While
some patients had a strong correlation between prostate
and seminal vesicle displacement in the AP and SI
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showed no significant relationship, indicating that the rela-
tionship is patient specific. The prostate and seminal
vesicle motion did not correlate in the LR direction.
From a clinical standpoint, our results have significant
implications when considering radiotherapy margins for
seminal vesicles especially in high risk prostate cancer
where the seminal vesicles are included in the target vol-
ume. Studies looking at interfraction seminal vesicle mo-
tion show that the seminal vesicles move more than the
prostate [9]. Interfraction seminal vesicle motion has
been assessed by Frank et al. using serial pre-treatment
CTs, who demonstrated that the mean 3D vector displace-
ment for the prostate was 4.6 mm and for the seminal
vesicle it was 7.6 mm [7]. Liang et al. studied seminal
vesicle interfraction motion and found that minimum
margins of 3 mm for prostate and 4.5 mm for SV were re-
quired for IMRT with prostate only image guidance [8].
Our study however is the first confirming that the intra-
fraction margin for seminal vesicles is also greater, which
is the foremost uncertainty once interfraction motion is
corrected for with IGRT of the prostate.
In addition, the movement of the seminal vesicles was
weakly correlated with the movement of the prostate for
most patients, which has implications for real time pros-
tate tracking techniques. For example, the Calypso® trans-
ponder is being increasingly used for IGRT while tracking
to the prostate, where the treatment can be stopped and
patient repositioned if the prostate displaces above a
predefined threshold. For example, using data from the
Calyso® system, Curtis et al. estimated that 1, 2, and
3 mm vector planning margins require a respective im-
aging frequency of every 15, 60, and 240 seconds to ac-
count for intrafraction prostate motion while achieving
adequate geometric target coverage for 95% of the time
[17]. However if the seminal vesicles are also included
in the volume, our study shows that additional margins
are required for the seminal vesicles as tracking to the
prostate is not a reliable surrogate for seminal vesicles.
As radiotherapy techniques become more sophisticated,
for example with better target delineation using MRI,
better IGRT for example with MRI linacs, and even
adaptive replanning to individualize treatment, there is
an attempt to also re-define and reduce the CTV-PTV
margins. However, the further understanding of the bio-
mechanics of the target must guide the development of
algorithms that are used in radiation planning and ther-
apy to produce a meaningful PTV rather than just static
geometric ones.
There are some of limitations of this study. Firstly CTV
to PTV margins also include uncertainties other than geo-
metrical displacement which have not been measured in
this study. For example contouring uncertainty, mechan-
ical limitations of the linear accelerator and software arealso factored into the PTV margin [18]. Deformation of
the seminal vesicles is also more prominent compared to
deformation of the prostate [9], and because our software
calculated displacement of the centroids of prostates and
seminal vesicles intrafraction deformation is not measured
in this study. In addition, although we have looked at 95%
of displacements, the clinical relevance of a displacement
becomes more significant if it is not momentary, and it is
as yet undefined what duration of displacement is clinic-
ally significant. Future studies looking at seminal vesicle
motion should also investigate dosimetric coverage.
Conclusion
Seminal vesicles moved significantly more than the pros-
tate in the SI direction, but not in the AP or LR direction.
Prostate and seminal vesicle displacement increased with
treatment time in the AP and SI direction. When setting
up to the prostate, larger margins are required for seminal
vesicles in the SI direction. The movement of the seminal
vesicles were weakly correlated with the movement of the
prostate, which has implications for real time prostate
tracking techniques if the intent is to treat the seminal
vesicles at the same time.
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